(MENAFN- ProactiveInvestors)On Wednesday investors will get an insight into the troubled mining sector when Glencore reports interims. Slumping commodity prices and concerns over the health of China's commodity consuming economy provide the backdrop. 'Both the group's traditional Mining and Marketing businesses are likely to have been pressured with first half production proving mixed.' Keith Bowman at Hargreaves Lansdown said. Investec said: 'We anticipate further substantial changes at the company's interim results on 19 August when we expect Glencore to provide more detail on the work that is underway to adapt to the increasingly challenging commodity environment.' Elsewhere Hikma Pharmaceuticals will report for the first time since it acquired Roxane Laboratories a move which was welcomed by the markets. 'It helps the company diversify away from its reliance on the Middle East and North Africa' analysts at The Share Centre said adding 'It will also give them a large pool of R&D assets to work on. Investors will expect further commentary on the benefits and any cost synergies from this business. Meanwhile in economic news investors need look no further than the Federal Reserve meeting minutes. Always an eye-catcher analysts will look to glean any clues on the likely timeframe for an interest rate hike. 'This should give us some clue as to the level of confidence there is among voting members to get started on rate hikes in the September meeting' Ben Gutteridge at Brewin Dolphin said. Wednesday Interims: Admiral Group (LON:ADM) Hochschild Mining (LON:HOC) Glencore (LON:GLEN) EnQuest (LON:ENQ) Hikma Pharmaceuticals (LON:HIK) Inspired Energy plc (LON:INSE) Trading statement: Imperial Tobacco Group (LON:IMT) Economic: EU – Balance of Payments Current Account US – CPI Crude Oil Inventories FOMC Interest Rate Minutes
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.